Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.621.1 (Mu)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.7.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BQ.1.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
CK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.16.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.16.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.517ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.517ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.291ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.291ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
B.1.258ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.349ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.349ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.314ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.314ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.132ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.132ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
BA.5.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16811.6China
BQ.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
CK.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used